Research Study
View Full Study →
The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatment
Citation
Amenta F et al. (2014). The ASCOMALVA Trial: interim results after two years of treatment. Journal of Alzheimer's Disease.
Abstract
View on PubMed.
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.